R&D Systems™ Recombinant Mouse B7-1/CD80 Fc Chimera His-tag Protein

Catalog No.	Quantity
74-0B1-01M	1 mg

Catalog No. 74-0B1-01M Supplier R&D Systems™ Supplier No. 740B101M

Description

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity

Measured by its ability to induce IL-2 secretion by Jurkat human acute T cell leukemia cells. Freeman, G.J. et al. (1993) Science 262:909. The ED50 for this effect is 5-30 ng/mL in the presence of PHA.

Specifications

• Accession Number: Q00609
• Characterization: Bioactivity
• For Use With (Application): Bioactivity
• Formulation: Lyophilized from a 0.2 μm filtered solution in PBS.
• Gene ID (Entrez): 941
• Molecular Weight (g/mol): M.W. (Observed): 80-90 kDa, reducing conditions; M.W. (theoretical): 51.3 kDa (monomer)
• Quantity: 1 mg
• Source: Mouse myeloma cell line, NS0-derived mouse B7-1/CD80 protein Mouse B7-1 (Asp37-Lys245) (N-terminus) Accession # Q00609 DIEGRMD Human IgG1 (Pro100-Lys330) 6-His tag (C-terminus)
• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20°C to -70°C as supplied. 1 month, 2°C to 8°C under sterile conditions after reconstitution. 3 months, -20°C to -70°C under sterile conditions after reconstitution.
• Endotoxin Concentration: <0.10 EU / 1 μg of the protein by the LAL method.
• Gene Alias: Activation B7-1 antigen, B7, B71, BB1, CD28LG1, CD28LGB7-1 antigen), CD80, CD80 antigen, CD80 molecule, costimulatory factor CD80, costimulatory molecule variant IgV-CD80, CTLA-4 counter-receptor B7.1, T-lymphocyte activation antigen CD80
• Gene Symbol: Cd80
• Product Type: Recombinant Protein
• Conjugate: Unconjugated
• Species: Mouse
• Reconstitution: Reconstitute at 100 μg/mL in sterile, deionized water.
• Purity or Quality Grade: >90%, by SDS-PAGE under reducing conditions and visualized by silver stain.
• Protein: B7-1/CD80